SciSparc Ltd. (SPRC) income statement
SPRCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$0.27−0.06 (-18.08%)
Close on Nov 18, 2026Market cap $98.71KP/E 0.0Yield –
SciSparc Ltd. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 73.7%
- Operating margin
- -978.3%
- Net margin
- -1422.8%
- Return on equity, FY2025
- -196.5%
Financial strength
- Current ratio
- 0.87
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 69.7%
Valuation
- P/E ratio
- 0.0
- Price to sales
- 0.12
- Price to book
- 0.03
- Dividend yield
- –
See a number that looks wrong?